Credit score: JCI Perception (2025). DOI: 10.1172/jci.perception.184975
The sCD13 protein has been beforehand recognized by a rheumatology analysis crew on the College of Michigan as a strong inducer of irritation in a number of autoimmune issues, reminiscent of rheumatoid arthritis and systemic sclerosis.
Excessive ranges of the sCD13 protein are additionally now being seen in blood and lung tissues of COVID-19 sufferers.
Researchers from College of Michigan Well being, in collaboration with exterior establishments such because the NIH and Weill Cornell Medical College, have been capable of establish this protein as a distinguished explanation for irritation within the SARS-CoV-2 an infection, extra generally often called COVID-19, utilizing information units from three separate cohorts of COVID-19 sufferers.
The work is revealed within the journal JCI Perception.
Formation of the sCD13 protein happens by shedding of CD13 from the floor of sure kinds of cells, by way of a course of that happens in autoimmune issues and because the physique makes an attempt to battle off the COVID-19 virus.
When this response is extreme, it’s termed hyperinflammatory, and may exacerbate the severity of the illness.
The inflammatory response of elevated quantities of sCD13 in COVID-19 sufferers is generally situated within the lungs, the place the virus ranges are highest. Problems embody respiratory failure requiring supplemental oxygen and mechanical air flow. Further problems embody the formation of blood clots inside small arteries of the lung.
These clots hinder the stream of blood by way of the lung.
In some illnesses, the formation of blood clots may be attributable to NETs, neutrophil extracellular traps, that are sticky webs which can be extruded by the neutrophil, a kind of white blood cell.
Of their analysis on sCD13 in COVID-19, the U-M Well being researchers confirmed that sCD13 prompted NET formation, following binding of sCD13 to 2 kinds of receptors on the floor of the neutrophil.
“In severe cases of COVID-19, this inflammation in the lungs can lead to acute respiratory distress syndrome, which causes difficulty breathing and can result in significant respiratory failure,” stated Eliza Tsou, Ph.D., assistant professor of inner drugs at College of Michigan Well being.
“When determining the severity of a COVID-19 infection, especially in patients that are experiencing extreme respiratory symptoms due to the virus, physicians can assess the level of sCD13 proteins as an indicator of the severity of the hyperinflammatory response within the patient.”
Tsou notes that proof of the sCD13 protein impacting irritation in COVID-19 additionally opens new avenues for remedy of the virus.
“The sCD13 protein and its receptors have emerged as new targets for treatment in pre-clinical trials for conditions such as rheumatoid arthritis and systemic sclerosis with success in animal models of these diseases,” stated Tsou.
“As these treatment methods move into their clinical trials, it is important for researchers and providers to note that targeting the sCD13 protein also has a potential future role in the treatment of severe COVID-19 cases.”
Extra data:
Pei-Suen Tsou et al, Soluble CD13 is a possible mediator of neutrophil-induced thrombogenic irritation in SARS-CoV-2 an infection, JCI Perception (2025). DOI: 10.1172/jci.perception.184975
Offered by
College of Michigan
Quotation:
Protein present in rheumatic illnesses causes irritation in COVID-19 sufferers (2025, Might 9)
retrieved 9 Might 2025
from https://medicalxpress.com/information/2025-05-protein-rheumatic-diseases-inflammation-covid.html
This doc is topic to copyright. Other than any honest dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is offered for data functions solely.
